Biologics
-
Biologics
Medtech Matters: FDA’s Ambiguity on Hyaluronic Acid
MPO's Sean Fenske speaks with Mike Daley of OrthogenRx about the role HA plays in alleviating knee pain and the challenges with the FDA over it.Sean Fenske, Editor-in-Chief 03.02.21
-
Biologics
Paragon 28 Launches MgNum Bone Void Filler
Expands its biologics portfolio.Charles Sternberg, Assistant Editor 02.22.21
-
Biologics
Washington University Professor Honored for Functional Cartilage Engineering Research
Scholar's research is soon expected to begin a Phase I clinical trial.Michael Barbella, Managing Editor 02.22.21
-
Biologics
Ranfac, Endocellutions Form Cervos Medical
Cervos Medical represents a joint venture to bring next generation surgical and orthobiologic devices to the market.Sean Fenske, Editor-in-Chief 02.19.21
-
Biologics
The FDA’s Flip-Flop on Hyaluronic Acid
Offering an introduction to this treatment modality for osteoarthritis, this article also looks at recent changes at FDA.Online Exclusives Mike Daley, CEO, OrthogenRx 02.10.21
-
Biologics
Helping Nature Take Its Course: A Biologics Breakdown
Examining the technologies designed to help the body heal itself following orthopedic and spinal surgery.Sam Brusco, Associate Editor 02.08.21
-
Biologics
An FDA Regulatory Perspective on Bone Grafts
There are various bone grafts with different composition, source, mechanical strength, and functional biological mechanisms.Mehdi Kazemzadeh-Narbat, Ph.D., Senior Associate, Regulatory Affairs, MCRA LLC 02.08.21
-
Biologics | Trauma/Sports
Geistlich Pharma's Chondro-Gide Articular Cartilage Cover Earns Breakthrough Status
The collagen membrane is used in a single-step cartilage repair technique.Sam Brusco, Associate Editor 02.03.21
-
Biologics
FDA Breakthrough Device Designation Granted to Spiderwort's Spinal Cord Technology
Company's biomaterial uses a plant-based cellulose scaffolding to create a framework that supports the regeneration of healthy tissues.Spiderwort Inc. 01.20.21
-
Biologics
Surgalign Launches New Device for Bone Formation
ViBone Moldable is the newest orthobiologics solution of Surgalign’s bone graft portfolio to support spinal fusion.GlobeNewswire 01.13.21
-
Biologics
Locate Bio’s CognitOss for Chronic Osteomyelitis Earns Breakthrough Status
Combines resorbable bone graft with bone healing properties and proprietary dual-phasic release of antibiotics.Business Wire 01.11.21
-
Biologics
Evonik Launches Next-Generation PEEK Biomaterial for Medtech Applications
VESTAKEEP iC4800's mechanical properties are similar to those of human bone.Evonik Industries AG 12.03.20
-
Biologics | Spine/Neurology
Surgalign, Aziyo Biologics Expand Distribution Deal
Boosts availability of ViBone Moldable, a next-gen moldable cellular bone matrix product.GlobeNewswire 11.17.20
-
Biologics
i-FACTOR + Matrix Launches in Canada
Becomes the first market to offer the i-FACTOR+ MATRIX.Cerapedics 11.05.20
-
Biologics
Orthobiologics Market to Reach $8.7 Billion By 2027
Approval and launch of new products are expected to propel the market's growth.Coherent Market Insights 10.29.20
-
Biologics
Avitus Orthopaedics Launches Bone Harvester
Empowers surgeons to tackle a full spectrum of bone harvesting needs.Avitus Orthopaedics 10.27.20
-
Biologics
Biologica Technologies Introduces OsseoGEN Cellular Bone Matrix
Company also announces first surgical cases using the product.PR Newswire 10.09.20
-
Biologics
Bioventus Reaches Two Million DUROLANE Treatments Worldwide
The original single-injection hyaluronic acid therapy has helped patients in nearly 30 countries.Business Wire 09.23.20
-
Biologics
Cerapedics Receives Canadian Approval for Next-Gen Bone Graft
The first country to approve the commercial launch of i-FACTOR+ Matrix.Cerapedics 09.16.20
-
3-D Printing/Additive Mfg. | Biologics
ODT’s Editorial Advisory Board Reflects on 15 Years
ODT reached out to members of its Editorial Advisory Board to help celebrate the brand's 15th birthday.Michael Barbella, Managing Editor 09.15.20
